HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 278, Issue 41, 39851-39857, October 10, 2003

This Article Full Text Full Text (PDF) All Versions of this Article: 278/41/39851    most recent M301618200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Park, S. G. Articles by Jung, G. Search for Related Content PubMed PubMed Citation Articles by Park, S. G. Articles by Jung, G. Social Bookmarking                      What's this?

Antisense Oligodeoxynucleotides Targeted against Molecular Chaperonin Hsp60 Block Human Hepatitis B Virus Replication^*

Sung Gyoo Park , Soo Min Lee  and Guhung Jung 

From the School of Biological Sciences, Seoul National University, Seoul, 151-742, Korea

The major role of hepatitis B virus polymerase (HBV pol) is polymerization of nucleotides, but it also participates in protein priming and the packaging of its own genome into capsids. Therefore, HBV pol may require many assistance factors for its roles. Previous reports have shown that Hsp60, a molecular chaperone, activates HBV pol both in vitro and ex vivo, such as inside insect cells. Moreover, HBV pol binds to Hsp60 in the HepG2 host cell line. In this report, we show that Hsp60 plays a role in the in vivo replication of HBV. Antisense oligodeoxynucleotides (A-ODNs) specifically directed against Hsp60 induced its down-regulation, severely reducing the level of replication-competent HBV without influencing cell proliferation and capsid assembly under these conditions. Furthermore, we found that Hsp60 did not encapsidate into nucleocapsids. Our results indicate that Hsp60 is important for HBV replication in vivo, presumably through activation of HBV pol before encapsidation of HBV pol into HBV core particle. In addition, A-ODNs specific for Hsp60 also inhibit replication of a mutant HBV strain that is resistant to the nucleoside analogue 3TC, which is the main drug used for HBV treatment, and we suggest that A-ODNs directed against Hsp60 are possible reagents as anti-HBV drugs. Conclusively, this report shows that the host factor, Hsp60, is essential for in vivo HBV replication and that mechanism of Hsp60 is probably through an activation of HBV pol by Hsp60.

Received for publication, February 14, 2003 , and in revised form, June 27, 2003.

^* This work was supported in part by a grant from the Korean Ministry of Science and Technology (Critical Technology 21 on "Life Phenomena and Function Research") (Grant 01-J-LF-01-B-70). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Supported by a BK21 Research Fellowship from the Ministry of Education and Human Resources Development.

To whom correspondence should be addressed. Tel.: 82-2-880-7773; Fax: 82-2-886-2117; E-mail: drjung{at}snu.ac.kr.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. G. Park, C. Chung, H. Kang, J.-Y. Kim, and G. Jung Up-regulation of Cyclin D1 by HBx Is Mediated by NF-{kappa}B2/BCL3 Complex through {kappa}B Site of Cyclin D1 Promoter J. Biol. Chem., October 20, 2006; 281(42): 31770 - 31777. [Abstract] [Full Text] [PDF]

				T. M. Abraham and D. D. Loeb Base Pairing between the 5' Half of {varepsilon} and a cis-Acting Sequence, {Phi}, Makes a Contribution to the Synthesis of Minus-Strand DNA for Human Hepatitis B Virus J. Virol., May 1, 2006; 80(9): 4380 - 4387. [Abstract] [Full Text] [PDF]